Clinical trial Recruiting at 2 sites Interventional Ages 18 to 85

Erector spinae plane block for managing pain after breast cancer surgery

Official title: Impact of Erector Spinae Plane Block With Adjuvant Dexmedetomidine on Chronic Postsurgical Pain in Breast Cancer Patients: a Two-center Randomized Controlled Trial

Run by Peking University First Hospital · NCT05494502 · Data updated 2026-11-12

This study is testing if a special nerve block combined with a medication can help reduce pain and improve recovery for women after breast cancer surgery.

More Chronic Pain trials

Quick facts

Study typeInterventional
Ages18 Years to 85 Years
SexAll
Enrollment1206 (estimated)
SponsorPeking University First Hospital
Academic / other
Locations2 sites (Beijing, Beijing Municipality and 1 other locations)
StatusRecruiting
StartedMay 23, 2023
Main results expectedNovember 2025
Study endsJuly 2027
Registry record updatedJuly 31, 2025
Trial IDNCT05494502 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 85 scheduled for unilateral mastectomy due to primary breast cancer.

Probably not a fit

Patients with previous breast surgeries, chronic opioid dependence, or contraindications to the erector spinae plane block will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of the erector spinae plane block (ESPB) combined with dexmedetomidine in reducing chronic postsurgical pain (CPSP) in breast cancer patients undergoing mastectomy. The study aims to determine if this nerve block technique can improve pain management and enhance the quality of life for patients post-surgery. Participants will be randomly assigned to receive either the ESPB intervention or standard care, with outcomes measured over time to assess pain levels and overall recovery. The trial builds on previous findings that suggest regional anesthesia may help prevent CPSP and improve long-term outcomes.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the incidence of chronic pain in breast cancer patients after surgery, improving their quality of life.

How similar studies have gone: Previous studies have shown promising results with similar nerve block techniques in reducing chronic pain after breast surgery, indicating potential for success in this trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age of 18 years or over, but less than 85 years;
2. Scheduled to undergo mastectomy for primary unilateral breast cancer.

Exclusion Criteria:

1. Previous breast cancer surgery with an incision of \>2 cm;
2. Chronic opioid dependence or long-term intake of analgesic medicines (\>3 months);
3. Any contraindication to erector spinae plane block, including intrathoracic infection, infection at the puncture site, cancer invasion of the puncture site, severe spinal deformity, history of spinal surgery, and severe coagulopathy;
4. Inability to communicate in the preoperative period because of profound dementia, deafness, language barriers, or end-stage disease;
5. History of malignant tumor in other organs, or a current combination of malignant tumor of other organs;
6. History of coronary heart disease (diagnosed coronary stenosis, previous myocardial infarction, previous percutaneous coronary intervention or coronary artery bypass grafting); preoperative hepatic or renal impairment (alanine transaminase and/or aspartate transaminase ≥2 times of upper limit of normal, or serum creatinine\>133 µmol/L); history of peptic ulcer or hemorrhage; ASA classification IV or above;
7. Allergy to ropivacaine.

Where it's running

  • Peking University First Hospital
    Beijing, Beijing Municipality, China
    Recruiting
  • Beijing Cancer Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

  • Principal investigator: Dong-Xin Wang, M.D., Ph.D. — Peking University First Hospital
  • Study coordinator: Qiongfang Wu, M.D.
  • Email: wuqf91@163.com
  • Phone: +8618310161109

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.